Management of Gastrointestinal Stromal Tumors

  • Igor G. Elyash


Gastrointestinal stromal tumors (GISTs) are nonepithelial tumors of the gastrointestinal (GI) tract that express genes for protein tyrosine kinase receptors, such as KIT and platelet-derived growth factor receptor alpha (PDGFRA). They are typically found in patients with early satiety, vague abdominal pain, gastrointestinal bleeding, or at times found incidentally in asymptomatic patients. GISTs are best studied with upper endoscopy and computed tomography (CT) to determine their resectability. Resectable tumors are best treated surgically, followed by adjuvant treatment with the tyrosine kinase inhibitor, imatinib, if there is a high risk for recurrence. Nonresectable tumors are best treated with imatinib first. All patients must undergo strict surveillance after treatment.


Gastrointestinal stromal tumors Nonepithelial GI tumor KIT PDGFRA Early satiety Imatinib 

Suggested Reading

  1. Brunicardi FC. Schwartz’s principles of surgery. 10th ed. New York: McGraw Hill; 2015.Google Scholar
  2. Cameron JL, Cameron AM. Current surgical therapy. 11th ed. Philadelphia: Elsevier; 2014.Google Scholar
  3. Keung EZ, Raut CP. Management of gastrointestinal stromal tumors. Surg Clin North Am. 2017;97(2):437–52.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Igor G. Elyash
    • 1
  1. 1.Morristown Surgical AssociatesMorristown Medical CenterMorristownUSA

Personalised recommendations